Results 211 to 220 of about 4,753,986 (376)
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Molecular Oncology, EarlyView.Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen +2 morewiley +1 more sourceVariant interpretation is a component of clinical practice among genetic counselors in multiple specialties [PDF]
, 2019 Karen E. Wain, Danielle R. Azzariti, Jennifer Goldstein, Amy Knight Johnson, Patti Krautscheid, Brianna Lepore, Julianne O’Daniel, Deborah Ritter, Juliann M. Savatt, Erin Rooney Riggs, Christa Lese Martin +10 moreopenalex +1 more sourceIdentification of common genetic risk variants for autism spectrum disorder
Nature Genetics, 2019 J. Grove, S. Ripke, T. Als, M. Mattheisen, R. Walters, H. Won, Jonatan Pallesen, E. Agerbo, O. Andreassen, R. Anney, Swapnil Awashti, R. Belliveau, F. Bettella, J. Buxbaum, J. Bybjerg-Grauholm, Marie Bækvad-Hansen, Felecia Cerrato, K. Chambert, J. Christensen, C. Churchhouse, Karin Dellenvall, D. Demontis, S. Rubeis, B. Devlin, S. Djurovic, Ashley L. Dumont, J. Goldstein, C. Hansen, M. Hauberg, M. Hollegaard, S. Hope, D. Howrigan, Hailiang Huang, C. Hultman, L. Klei, J. Maller, Joanna Martin, Alicia R. Martin, J. Moran, M. Nyegaard, T. Nærland, D. Palmer, A. Palotie, C. Pedersen, M. Pedersen, Timothy dPoterba, J. Poulsen, B. S. Pourcain, P. Qvist, K. Rehnström, A. Reichenberg, J. Reichert, E. Robinson, K. Roeder, P. Roussos, E. Saemundsen, S. Sandin, F. Satterstrom, G. D. Smith, H. Stefánsson, S. Steinberg, C. Stevens, P. Sullivan, P. Turley, G. Walters, Xinyi Xu, N. Wray, M. Trzaskowski, Enda M. Byrne, A. Abdellaoui, M. Adams, T. Air, Till F. M. Andlauer, S. Bacanu, A. Beekman, T. Bigdeli, E. Binder, D. Blackwood, J. Bryois, H. Buttenschøn, N. Cai, E. Castelao, Toni‐Kim Clarke, J. Coleman, L. Colodro-Conde, B. Couvy-Duchesne, N. Craddock, Gregory E. Crawford, G. Davies, I. Deary, F. Degenhardt, E. Derks, N. Direk, C. Dolan, E. Dunn, T. Eley, V. Escott-Price, Farnush Farhadi Hassan Kiadeh, H. Finucane, A. Forstner, J. Frank, Héléna A. Gaspar, M. Gill, F. Goes, S. Gordon, L. Hall, T. Hansen, S. Herms, I. Hickie, P. Hoffmann, G. Homuth, Carsten Horn, J. Hottenga, M. Ising, R. Jansen, E. Jorgenson, J. Knowles, I. Kohane, J. Kraft, Warren W. Kretzschmar, J. Krogh, Z. Kutalik, Yihan Li, P. Lind, D. Macintyre, D. MacKinnon, Robert M. Maier, Wolfgang Maier, J. Marchini, H. Mbarek, Patrick J. McGrath, P. McGuffin, S. Medland, D. Mehta, C. Middeldorp, E. Mihailov, Y. Milaneschi, L. Milani, Francis M. Mondimore, G. Montgomery, S. Mostafavi, N. Mullins, M. Nauck, B. Ng, M. Nivard, D. Nyholt, P. O’Reilly, H. Oskarsson, M. Owen, J. Painter, Roseann E. Peterson, E. Pettersson, W. Peyrot, G. Pistis, D. Posthuma, J. Quiroz, John P. Rice, B. Riley, M. Rivera, S. Mirza, R. Schoevers, E. Schulte, L. Shen, Jianxin Shi, Stanley I. Shyn, E. Sigurdsson, Grant C. B. Sinnamon, J. Smit, Daniel J. Smith, F. Streit, J. Strohmaier, K. Tansey, H. Teismann, A. Teumer, Wesley Thompson, P. Thomson, T. Thorgeirsson, M. Traylor, J. Treutlein, V. Trubetskoy, A. Uitterlinden, D. Umbricht, S. Auwera, A. M. Hemert, A. Viktorin, P. Visscher, Yunpeng Wang, B. Webb, S.M. Weinsheimer, J. Wellmann, G. Willemsen, S. Witt, Yang Wu, H. Xi, Jian Yang, Futao Zhang, V. Arolt, B. Baune, K. Berger, D. Boomsma, S. Cichon, U. Dannlowski, E. D. Geus, J. DePaulo, E. Domenici, K. Domschke, T. Esko, H. Grabe, S. Hamilton, C. Hayward, A. Heath, K. Kendler, S. Kloiber, G. Lewis, Qingqin S. Li, S. Lucae, P. Madden, P. Magnusson, N. G. Martin, A. McIntosh, A. Metspalu, B. Müller-Myhsok, M. Nöthen, M. O’Donovan, S. Paciga, N. Pedersen, B. Penninx, R. Perlis, D. Porteous, J. Potash, M. Preisig, M. Rietschel, C. Schaefer, T. Schulze, J. Smoller, H. Tiemeier, R. Uher, H. Völzke, Myrna M. Weissman, C. Lewis, D. Levinson, G. Breen, M. Agee, B. Alipanahi, A. Auton, R. Bell, K. Bryc, S. Elson, P. Fontanillas, N. Furlotte, Bethann S. Hromatka, K. Huber, A. Kleinman, N. Litterman, M. Mcintyre, J. Mountain, E. Noblin, C. Northover, S. Pitts, J. Sathirapongsasuti, O. V. Sazonova, J. Shelton, S. Shringarpure, J. Tung, V. Vacic, C. H. Wilson, K. Stefánsson, D. Geschwind, M. Nordentoft, D. Hougaard, T. Werge, O. Mors, P. Mortensen, B. Neale, M. Daly, A. Børglum +275 moresemanticscholar +1 more sourceIntein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar +9 morewiley +1 more sourceClass IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer
Molecular Oncology, EarlyView.HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio +13 morewiley +1 more sourceIn vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations
Molecular Oncology, EarlyView.Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow +10 morewiley +1 more sourceYield on Reinterpretation of Genetic Variants in Pediatric Cardiomyopathy. [PDF]
J Am Heart AssocSuzuki T, Lesurf R, Akilen R, Xu X, Batke EM, Rao VJ, Jobling R, Zahavich L, Henden N, Ingles J, Torres EA, Hirono K, Roux-Buisson N, Dhandapany PS, Sandmann C, Mital S. +15 moreeuropepmc +1 more sourceMaternally inherited genetic variants of CADPS 2 are present in Autism Spectrum Disorders and Intellectual Disability patients
, 2014 Elena Bonora, Claudio Graziano, Fiorella Minopoli, Elena Bacchelli, Pamela Magini, Chiara Diquigiovanni, Silvia Lomartire, Francesca Bianco, Manuela Vargiolu, Piero Parchi, Elena Marasco, Vilma Mantovani, Luca Rampoldi, Matteo Trudu, Antonia Parmeggiani, Agatino Battaglia, Luigi Mazzone, Giada Tortora, Elena Maestrini, Marco Seri, Giovanni Romeo +20 moreopenalex +1 more sourceGenetic variants at 5p15 are associated with risk and early onset of gastric cancer in Chinese populations [PDF]
, 2013 Jiangbo Du, Yaochu Xu, Juncheng Dai, Chuanli Ren, Zhu Chen, Ningbin Dai, Hongxia Ma, Yongyong Shi, Zhibin Hu, Dongxin Lin, Hongbing Shen, Guangfu Jin +11 moreopenalex +1 more source
